Saturday, September 4, 2021

RIL arm buys majority stake in Strand Life Sciences for Rs 393 crore

RIL is expected to further invest up to Rs 160 crore in the genomic testing firm by March, 2023

from Today's Paper https://ift.tt/3h3eYUa
via
By at
Labels: ,

No comments:

Post a Comment

If you have any doubts please let me know!

Subscribe to: Post Comments (Atom)

India's low score on GVC a starting point for recovery from pandemic: AIIB

India rated 7.4 percentage points below the average global value chain participation rate for emerging economies from Today's Paper ht...